Delivery Order SPE2DE21D7020-SPE2D625F8EX9
- Not listed
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $41,639.42 to Boston Scientific Corp for agent drug-coated balloons, with an ultimate completion date of September 22, 2025. This fixed-price contract with economic price adjustment was issued without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The award leverages Boston Scientific's established capabilities as a major supplier of advanced cardiovascular...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $26,532.60 to Boston Scientific Corp for agent drug-coated balloon medical devices. The contract, issued on August 18, 2025, carries a fixed-price pricing structure with economic price adjustment provisions and has an ultimate completion date of August 25, 2025. This delivery order represents a continuation of Boston Scientific's role as a key supplier of specialized cardiovascular intervention equipment to...
- The Defense Health Agency's Medical Supply Chain has awarded a delivery order to Boston Scientific Corp for agent drug-coated balloons, with a ceiling value of approximately $19.9K and an ultimate completion date of September 22, 2025. This fixed-price contract with economic price adjustment provisions was awarded on September 15, 2025, with no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's...
- The U.S. Department of Defense's Medical Supply Chain awarded a fixed-price delivery order valued at $17,802.20 to Boston Scientific Corp for agent drug-coated balloons. Issued on September 10, 2025, with an ultimate completion date of September 17, 2025, this delivery order represents a competitive award with no set-aside designation. The contract will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures and distributes the specialized...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $8,714.55 to Boston Scientific Corp for drug-coated balloons, with performance scheduled to conclude by July 25, 2025. This fixed-price delivery order with economic price adjustment represents a competitive contract with no set-aside designation. Boston Scientific, headquartered in Marlborough, Massachusetts, will perform work at its primary facility in the same location. The contract exemplifies the ongoing...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp for drug-coated balloons on September 10, 2025, with a contract ceiling value of $6,175 and an ultimate completion date of September 17, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's facility in Marlborough,...
- The Defense Health Agency's Medical Supply Chain awarded Boston Scientific Corp a fixed-price delivery order valued at $7,524.80 for drug-coated balloon medical devices, with an ultimate completion date of August 29, 2025. The contract, which is not set-aside and uses economic price adjustment pricing, will be performed at Boston Scientific's Marlborough, Massachusetts facility. This delivery order represents a discrete procurement under the agency's broader medical device supply chain...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $18,953.95 for agent drug-coated balloon supplies. The contract, awarded on June 6, 2025, with an ultimate completion date of June 11, 2025, is funded through the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment represents Boston Scientific's continued role as a critical supplier...
- Boston Scientific Corp has been awarded a delivery order valued at $8,150.20 for agent drug-coated balloons under a Defense Health Agency Medical Supply Chain contract. The award, issued on September 16, 2025, with a completion date of September 19, 2025, utilizes fixed-price pricing with economic price adjustment terms. The contract carries no set-aside designation, indicating open competition in the federal marketplace. Performance will be executed at Boston Scientific's Marlborough,...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $18,918.66 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on June 27, 2025. The contract is structured as a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of July 7, 2025. The place of performance is located in Marlborough, MA, where Boston Scientific...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F8EX9Delivery Order
The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $21,014.55 to Boston Scientific Corp for agent drug-coated balloons, with an ultimate completion date of July 30, 2025. This fixed-price contract with economic price adjustment was issued without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at the company's facility in Marlborough, Massachusetts, where Boston Scientific manufactures and distributes its comprehensive portfolio of cardiovascular and interventional medical devices. This delivery order represents a task order issued under Boston Scientific's larger indefinite delivery vehicle relationship with the Defense Health Agency. As a major federal medical device contractor, Boston Scientific provides the Department of Defense and affiliated healthcare agencies with critical medical technologies, including stents, catheters, pacemakers, and other cardiovascular intervention tools. Drug-coated balloons are specialized interventional cardiology devices used in percutaneous coronary interventions, and this award demonstrates Boston Scientific's continued role as a key supplier of advanced medical technologies to the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.0k | 7/23/25 |